Prescription drug · ANDA
Furosemide NDC 25021-320
Furosemide 10 mg/mL · Injection, Solution · Intramuscular, Intravenous · Sagent Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25021-320-02 | 25021032002 | 25 VIAL in 1 CARTON (25021-320-02) / 2 mL in 1 VIALMarketed from Jul 15, 2025 | |
| 25021-320-04 | 25021032004 | 25 VIAL in 1 CARTON (25021-320-04) / 4 mL in 1 VIALMarketed from Jul 15, 2025 | |
| 25021-320-10 | 25021032010 | 25 VIAL in 1 CARTON (25021-320-10) / 10 mL in 1 VIALMarketed from Jul 15, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furosemide
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 10 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Sagent PharmaceuticalsNDC labeler code 25021
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214766
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 25021-320_29372fb6-0fa1-4caf-a55f-451091c93390SPL ID 29372fb6-0fa1-4caf-a55f-451091c93390SPL set ID d76bd85a-8e57-477e-9607-c9435f1e26fbRxCUI 1719286, 1719290, 1719291UNII 7LXU5N7ZO5
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N425021032002followed by a unit qualifier and the quantityPackage 25021-0320-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. Edema Furosemide Injection is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide Injection is particularly useful when an agent with greater diuretic potential is desired. Furosemide Injection is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of Furosemide Injection is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema. …
Excerpt only. Read the full label for complete information.
About NDC 25021-320
- What is NDC 25021-320?
- 25021-320 is the product NDC for Furosemide, Furosemide 10 mg/mL injection, solution, listed with the FDA by Sagent Pharmaceuticals. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Furosemide.
- What is the active ingredient?
- Furosemide.
- Who is the labeler?
- Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Furosemide?
- 211 other product NDCs are listed under this name. See all Furosemide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Furosemide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Civica, Inc. | 72572-275 | 72572-0275-10 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-033 | 87441-0033-01 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4679 | 70518-4679-00 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Coupler LLC | 67046-0768 | 67046-0768-03 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4609 | 70518-4609-00 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Coupler LLC | 67046-1663 | 67046-1663-03 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-832 | 10135-0832-0110135-0832-1010135-0832-90 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-833 | 10135-0833-0110135-0833-1010135-0833-90 |
| Furosemide | Furosemide 80 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-834 | 10135-0834-0110135-0834-0510135-0834-90 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0164 | 63561-0164-0163561-0164-0263561-0164-09 |